Cannella, Laura, Massimo Breccia, Giuseppina Loglisci, Vincenzo Federico, Michelina Santopietro, and Giuliana Alimena. “Safety and Efficacy of Nilotinib in Chronic Phase Chronic Myeloid Leukemia in a Patient With Wolf-Parkinson-White Disease and Hematological Resistance After Suboptimal Response to Imatinib at Six Months”. Acta Oncologica 49, no. 3 (January 1, 2010): 399–400. Accessed April 29, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/32601.